|
1
|
Bradley JD, El Naqa I, Drzymala RE, Trovo
M, Jones G and Denning MD: Stereotactic body radiation therapy for
Early-stage Non-small-cell lung cancer: The pattern of failure is
distant. Int J Radiat Oncol Biol Phys. 77:1146–1150. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Onishi H, Araki T, Shirato H, Nagata Y,
Hiraoka M, Gomi K, Yamashita T, Niibe Y, Karasawa K, Hayakawa K, et
al: Stereotactic hypofractionated high-dose irradiation for stage I
nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in
a Japanese multiinstitutional study. Cancer. 101:1623–1631. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Senthi S, Lagerwaard FJ, Haasbeek CJ,
Slotman BJ and Senan S: Patterns of disease recurrence after
stereotactic ablative radiotherapy for early stage Non-small-cell
lung cancer: A retrospective analysis. Lancet Oncol. 13:802–809.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schneider BJ, Ismaila N, Aerts J, Chiles
C, Daly ME, Detterbeck FC, Hearn JWD, Katz SI, Leighl NB, Levy B,
et al: Lung cancer surveillance after definitive curative-intent
therapy: ASCO guideline. J Clin Oncol. 38:753–766. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Postmus PE, Kerr KM, Oudkerk M, Senan S,
Waller DA, Vansteenkiste J, Escriu C and Peters S; ESMO Guidelines
Committee, : Early and locally advanced non-small-cell lung cancer
(NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 28 (Suppl_4):iv1–iv21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shintani T, Matsuo Y, Iizuka Y, Mitsuyoshi
T and Mizowaki T: A retrospective Long-term follow-up study of
stereotactic body radiation therapy for Non-small cell lung cancer
from a single institution: Incidence of late local recurrence. Int
J Radiat Oncol Biol Phys. 100:1228–1236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hamamoto Y, Kataoka M, Nogami N, Kozuki T,
Kato Y, Shinohara S and Shinkai T: Factors affecting survival time
after recurrence of non-small-cell lung cancer treated with
concurrent chemoradiotherapy. Jpn J Radiol. 30:249–254. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McAvoy S, Ciura K, Wei C, Rineer J, Liao
Z, Chang JY, Palmer MB, Cox JD, Komaki R and Gomez DR: Definitive
reirradiation for locoregionally recurrent non-small cell lung
cancer with proton beam therapy or intensity modulated radiation
therapy: Predictors of high-grade toxicity and survival outcomes.
Int J Radiat Oncol Biol Phys. 90:819–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sasaki H, Suzuki A, Tatematsu T, Shitara
M, Hikosaka Y, Okuda K, Moriyama S, Yano M and Fujii Y: Prognosis
of recurrent non-small cell lung cancer following complete
resection. Oncol Lett. 7:1300–1304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takenaka T, Yano T, Yamazaki K, Okamoto T,
Hamatake M, Shimokawa M and Mori M; Kyushu University Lung Surgery
Study Group Japan, : Survival after recurrence following surgical
resected non-small cell lung cancer: A multicenter, prospective
cohort study. JTCVS Open. 10:370–381. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lababede O and Meziane MA: The Eighth
edition of TNM staging of lung cancer: Reference chart and
diagrams. Oncologist. 23:844–848. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang K, Senthi S, Palma DA, Spoelstra FO,
Warner A, Slotman BJ and Senan S: High-risk CT features for
detection of local recurrence after stereotactic ablative
radiotherapy for lung cancer. Radiother Oncol. 109:51–57. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Woody NM, Stephans KL, Andrews M, Zhuang
T, Gopal P, Xia P, Farver CF, Raymond DP, Peacock CD, Cicenia J, et
al: A histologic basis for the efficacy of SBRT to the lung. J
Thorac Oncol. 12:510–519. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugawara Y, Braun DK, Kison PV, Russo JE,
Zasadny KR and Wahl RL: Rapid detection of human infections with
fluorine-18 fluorodeoxyglucose and positron emission tomography:
Preliminary results. Eur J Nucl Med. 25:1238–1243. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kubota R, Yamada S, Kubota K, Ishiwata K,
Tamahashi N and Ido T: Intratumoral distribution of
fluorine-18-fluorodeoxyglucose in vivo: High accumulation in
macrophages and granulation tissues studied by
microautoradiography. J Nucl Med. 33:1972–1980. 1992.PubMed/NCBI
|
|
17
|
Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku
Y and Handa H: Stereotactic body radiotherapy (SBRT) for solitary
pulmonary nodules clinically diagnosed as lung cancer with no
pathological confirmation: Comparison with non-small-cell lung
cancer. Lung Cancer. 77:77–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
